Access to Experimental Drugs: Expanding Right to Try
This act aims to broaden access to experimental drugs for patients with serious illnesses. It allows the use of substances that have completed initial safety trials, even if they are controlled substances. This provides patients with a potential treatment option when other avenues have been exhausted.
Key points
Expands patients' right to try experimental drugs, including certain controlled substances.
Grants access to drugs that have completed Phase I clinical trials and show promising results.
Offers hope to seriously ill patients for access to innovative therapies not yet fully approved.
Status:
Expired
Record your position for audit.
Why does your vote on bills matter?
It creates raw, undeniable proof. Civic Will provides the permanent data to verify the Government's loyalty towards its citizens
(explained here).
Start recording it now.